Pharmaceutical sales and medical device distribution built on a relentless track record of exceeding targets, opening markets, and delivering measurable revenue growth for our partners.
JM Distribution is a New Jersey-based pharmaceutical sales and medical device distribution company. Since 2020, we have consistently delivered results that set us apart in the industry.
We specialize in driving product adoption across the Northeast, partnering with healthcare providers and manufacturers to accelerate market penetration for GLP-1 therapies, peptide therapies, inhaler devices, and clinical medical equipment.
Our approach combines deep industry knowledge with an aggressive, results-driven methodology. We don't just meet targets — we consistently exceed them, year after year.
Transformed territory performance with aggressive account acquisition and relationship building 2024–2025.
Expanded active territory coverage in both 2022 and 2025, opening new markets across the Northeast.
Grossed $475K in the second half of 2025, up from $435K in the same period of 2023.
Specialized distribution across four high-growth therapeutic categories, with proven market penetration in the Northeast.
JM Distribution has established a dominant presence in the GLP-1 therapy market across the Northeast, opening 50+ new accounts in dermatology offices alone in 2025. With 134% clinical quota achievement, we have become the go-to distribution partner for GLP-1 adoption across the region.
Our deep clinical knowledge and provider relationships enable rapid market entry and sustained adoption for manufacturers entering or expanding in this category.
Peptide therapies require specialized knowledge and trusted provider relationships to gain clinical adoption. JM Distribution brings both — combining deep biochemical understanding with a proven Northeast network of healthcare providers who trust our recommendations.
Our results-first approach to peptide placement has built lasting partnerships that drive consistent recurring revenue for our manufacturing partners.
JM Distribution has secured 40+ inhaler device accounts across the Northeast, with full-cycle sales expertise from prospecting to clinical trial close. Our deep understanding of respiratory therapy protocols makes us the trusted partner for manufacturers entering this competitive market.
Proven track record of building long-term inhaler accounts with recurring revenue and high provider retention rates.
Capital and clinical medical device sales across the Northeast. Achieved 106% of capital quota targets with consistent year-over-year growth. From large capital equipment to clinical consumables, JM Distribution has the relationships and expertise to drive adoption.
Clinical diagnostic tools and analyzers for healthcare facilities.
IV infusion pumps and delivery systems for acute care settings.
Patient monitoring and vital signs equipment for clinical use.
Large capital medical equipment with full sales cycle support.
Consistent, measurable growth year after year across all product lines and territories.
Up from $435K in the same period of 2023. Consistent upward trajectory year over year.
Nearly doubled territory revenue through aggressive account acquisition and market expansion.
GLP-1 and peptide therapy accounts opened across dermatology offices in the Northeast.
Industry-leading closing rate across all product lines and territories.
Whether you're a healthcare provider looking for reliable pharmaceutical access or a manufacturer seeking aggressive market penetration across the Northeast, JM Distribution delivers.
Let's Talk →Whether you're a healthcare provider seeking reliable access to the latest pharmaceutical products, or a manufacturer looking for aggressive market penetration across the Northeast, JM Distribution is ready to deliver results.